费森尤斯Fresenius（FMS）2023年年度报告「NYSE」（英文版）（381页）.pdf

1、ANNUAL REPORT 2023Group in figures Table of contentsMedia HubTargets,results,and outlookFresenius is a global healthcare company.We offer system-critical products and services for therapies for care of critically and chronically ill patients.Fresenius com-prises the Operating Companies Fresenius Kab

2、i and Fresenius Helios as well as the Investment Companies Fresenius Vamed and Fresenius Medical Care.Operating CompaniesInvestment CompaniesFront page2Fresenius|Annual Report 2023Group in figures Table of contentsMedia HubTargets,results,and outlook in millions20232022202120202019 Revenue and earni

3、ngsRevenue 1 22,299 21,532 19,969 18,476 17,993 EBITDA 1,2 3,422 3,315 3,353 3,042 3,191 EBIT 1,2 2,262 2,190 2,337 2,113 2,332 Net income 1,2,3 1,505 1,729 1,8671,7961,879Depreciation and amortization 1,2 1,160 1,125 1,016 929 859 Earnings per share in 1,2,32.673.083.353.223.37Cash flow and balance

4、 sheetOperating cash flow 1 2,131 2,031 2,589 2,316 1,696 Free cash flow before acquisitions,dividends and lease liabilities 1 1,024 9421,401986376Free cash flow after acquisitions,dividends and lease liabilities 1 115-31838818-394Cash conversion rate 1 1.0 0.90.90.80.5Total assets45,284 76,400 71,9

5、62 66,646 67,006 Non-current assets32,764 58,121 54,501 50,874 51,742 Equity 4 19,651 32,218 29,288 26,023 26,580 Equity ratio 443%42%41%39%40%Net debt 1 13,268 13,316 12,650 13,021 12,980 Net debt/EBITDA 1,2,5 3.76 3.80 3.64 4.12 3.93 Investments 1,6 1,346 2,015 1,635 1,841 1,664 ProfitabilityEBIT

6、margin 1,210.1%10.2%11.7%11.4%13.0%Return on invested capital(ROIC)1,25.2%5.6%6.2%5.9%6.7%Dividend per share in 0.920.920.880.84Employees(December 31)1193,865 188,876 185,827 178,140 165,834 1 Prior-year figures have been adjusted due to the application of IFRS 5 to the deconsolidated operations of